The Early Access program is currently available in New Zealand, United Kingdom, Switzerland, Germany and Ireland (While the USA (FDA) approves treatments, the process is too costly and time consuming so American patients choose to fly abroad instead. While Australia approves treatments the administration has turned out to be costly so patients choose to fly to New Zealand instead.

Get in touch



United States

Contact Us:

The scientific literature has firmly established that mercury causes a biochemical train wreck especially in the brain where it is linked to a host of neurological illnesses and oxidative stress.

Boyd Haley, PhD, Chief Scientist and CEO


Learn about our company, mission and board of directors.

Early Access

Emeramide has been approved for compassionate use.


Latest News, Research, Clinical Trials, Press and Newsletters.

Discover The Future of Health

We are committed to improving health by way of our unique metal chelator and antioxidant, Emeramide

Contact Us